AAAAAA

   
Results: 1-25 | 26-50 | 51-52
Results: 1-25/52
PHASE-I TRIAL OF SUBCUTANEOUS RECOMBINANT HUMAN INTERLEUKIN-12 IN PATIENTS WITH ADVANCED RENAL-CELL CARCINOMA
Authors: MOTZER RJ RAKHIT A SCHWARTZ LH OLENCKI T MALONE TM SANDSTROM K NADEAU R PARMAR H BUKOWSKI R
Citation: Rj. Motzer et al., PHASE-I TRIAL OF SUBCUTANEOUS RECOMBINANT HUMAN INTERLEUKIN-12 IN PATIENTS WITH ADVANCED RENAL-CELL CARCINOMA, Clinical cancer research, 4(5), 1998, pp. 1183-1191
PHASE-I TRIAL OF SUBCUTANEOUS RECOMBINANT HUMAN INTERLEUKIN-12 IN PATIENTS WITH ADVANCED RENAL-CELL CARCINOMA
Authors: MOTZER RJ RAKHIT A SCHWARTZ LH OLENCKI T MALONE TM SANDSTROM K NADEAU R PARMAR H BUKOWSKI R
Citation: Rj. Motzer et al., PHASE-I TRIAL OF SUBCUTANEOUS RECOMBINANT HUMAN INTERLEUKIN-12 IN PATIENTS WITH ADVANCED RENAL-CELL CARCINOMA, Clinical cancer research, 4(5), 1998, pp. 1183-1191
ORAL 5-FLUOROURACIL (5-FU) PLUS ENILURACIL (776C85) IN PATIENTS WITH METASTATIC COLORECTAL-CANCER - A QUALITY-OF-LIFE (QOL) EVALUATION
Authors: SCHILSKY R BUKOWSKI R ROWINSKY E BURRIS H CRAWFORD J HOCHSTER H OROURKE M GLENDENNING A BARTON C
Citation: R. Schilsky et al., ORAL 5-FLUOROURACIL (5-FU) PLUS ENILURACIL (776C85) IN PATIENTS WITH METASTATIC COLORECTAL-CANCER - A QUALITY-OF-LIFE (QOL) EVALUATION, Annals of oncology, 9, 1998, pp. 168-168
DRUG-RESISTANCE IN HUMAN NONSMALL CELL LUNG-CARCINOMA - RELEVANCE OF MULTIDRUG-RESISTANT GENE-EXPRESSION AND SENSITIVITY TO TOPOISOMERASE OR MICROTUBULE POISONS
Authors: GANAPATHI R KIM S GRABOWSKI D AOYAMA M RICE T BUKOWSKI R GANAPATHI M
Citation: R. Ganapathi et al., DRUG-RESISTANCE IN HUMAN NONSMALL CELL LUNG-CARCINOMA - RELEVANCE OF MULTIDRUG-RESISTANT GENE-EXPRESSION AND SENSITIVITY TO TOPOISOMERASE OR MICROTUBULE POISONS, Annals of oncology, 9, 1998, pp. 577-577
EVIDENCE THAT TUMOR SUPPRESSES NF-KAPPA-B ACTIVATION IN T-CELLS OF PATIENTS WITH RENAL-CELL CARCINOMA (RCC)
Authors: UZZO RG CLARK PE RAYMOND P KLEIN E BUKOWSKI R NOVICK AC FINKE JH
Citation: Rg. Uzzo et al., EVIDENCE THAT TUMOR SUPPRESSES NF-KAPPA-B ACTIVATION IN T-CELLS OF PATIENTS WITH RENAL-CELL CARCINOMA (RCC), The Journal of urology, 159(5), 1998, pp. 572-572
CHARACTERIZATION OF CD95 CD95L EXPRESSION AND APOPTOSIS IN T-CELLS OFPATIENTS WITH RENAL-CARCINOMA (RCC)/
Authors: KOLENKO V UZZO RG CLARK PE RAYMAN P BUKOWSKI R TUBBS R NOVICK AC FINKE JH
Citation: V. Kolenko et al., CHARACTERIZATION OF CD95 CD95L EXPRESSION AND APOPTOSIS IN T-CELLS OFPATIENTS WITH RENAL-CARCINOMA (RCC)/, The Journal of urology, 159(5), 1998, pp. 657-657
RANDOMIZED, CONTROLLED TRIAL OF EX-VIVO ACTIVATED T-CELLS VS. INTERFERON-ALPHA IN METASTATIC RENAL-CANCER
Authors: SAWCZUK I PETRYLAK D BENEDETTO P BERRIS R BUKOWSKI R DREICER R EINSTEIN A ELLERHORST J GOODMAN G GRAHAM S HARRIS D KEMPF R KLAMET J KUZEL T LEONG S LOGAN T MEYERS F MILLER W MURPHY B MCCAFFREY R WALTHER P WILLIAMS D HAWKINS M
Citation: I. Sawczuk et al., RANDOMIZED, CONTROLLED TRIAL OF EX-VIVO ACTIVATED T-CELLS VS. INTERFERON-ALPHA IN METASTATIC RENAL-CANCER, The Journal of urology, 159(5), 1998, pp. 740-740
ADJUVANT SURGERY FOLLOWING BIOLOGICAL RESPONSE MODIFIER THERAPY EXTENDS SURVIVAL IN PATIENTS WITH METASTATIC RENAL-CELL CARCINOMA
Authors: KRISHNAMURTHI V NOVICK AC BUKOWSKI R
Citation: V. Krishnamurthi et al., ADJUVANT SURGERY FOLLOWING BIOLOGICAL RESPONSE MODIFIER THERAPY EXTENDS SURVIVAL IN PATIENTS WITH METASTATIC RENAL-CELL CARCINOMA, The Journal of urology, 159(5), 1998, pp. 763-763
AB-INITIO STUDY OF THE VAN-DER-WAALS INTERACTION OF NH(X-3-SIGMA(-)) WITH AR(S-1)
Authors: KENDALL RA CHALASINSKI G KLOS J BUKOWSKI R SEVERSON MW SZCZESNIAK MM CYBULSKI SM
Citation: Ra. Kendall et al., AB-INITIO STUDY OF THE VAN-DER-WAALS INTERACTION OF NH(X-3-SIGMA(-)) WITH AR(S-1), The Journal of chemical physics, 108(8), 1998, pp. 3235-3242
ANALYTIC FIRST-ORDER PROPERTIES FROM EXPLICITLY CORRELATED MANY-BODY PERTURBATION-THEORY AND GAUSSIAN GEMINAL BASIS
Authors: BUKOWSKI R JEZIORSKI B SZALEWICZ K
Citation: R. Bukowski et al., ANALYTIC FIRST-ORDER PROPERTIES FROM EXPLICITLY CORRELATED MANY-BODY PERTURBATION-THEORY AND GAUSSIAN GEMINAL BASIS, The Journal of chemical physics, 108(19), 1998, pp. 7946-7958
CLINICAL-PHARMACOLOGY OF INTERLEUKIN-12 (RHUIL-12), IN PATIENTS WITH RENAL-CELL CARCINOMA (RCC)
Authors: RAKHIT A MOTZER RJ PARMAR H PECK R HUBER M NADEAU R BUKOWSKI R
Citation: A. Rakhit et al., CLINICAL-PHARMACOLOGY OF INTERLEUKIN-12 (RHUIL-12), IN PATIENTS WITH RENAL-CELL CARCINOMA (RCC), Clinical pharmacology and therapeutics, 63(2), 1998, pp. 107-107
IMPAIRED ACTIVATION OF NF-KAPPA-B IN T-CELLS FROM A SUBSET OF RENAL-CELL CARCINOMA PATIENTS IS MEDIATED BY INHIBITION OF PHOSPHORYLATION AND DEGRADATION OF THE INHIBITOR, I-KAPPA-B-ALPHA
Authors: LING WJ RAYMAN P UZZO R CLARK P KIM HJ TUBBS R NOVICK A BUKOWSKI R HAMILTON T FINKE J
Citation: Wj. Ling et al., IMPAIRED ACTIVATION OF NF-KAPPA-B IN T-CELLS FROM A SUBSET OF RENAL-CELL CARCINOMA PATIENTS IS MEDIATED BY INHIBITION OF PHOSPHORYLATION AND DEGRADATION OF THE INHIBITOR, I-KAPPA-B-ALPHA, Blood, 92(4), 1998, pp. 1334-1341
PHASE-I STUDY OF INTERLEUKIN-4 (RHUIL-4) COMBINED WITH CHEMOTHERAPY IN GASTROINTESTINAL (GI) MALIGNANCIES
Authors: BUKOWSKI R WOLFF R HURWITZ H RYBAK ME ROSE E
Citation: R. Bukowski et al., PHASE-I STUDY OF INTERLEUKIN-4 (RHUIL-4) COMBINED WITH CHEMOTHERAPY IN GASTROINTESTINAL (GI) MALIGNANCIES, European journal of cancer, 33, 1997, pp. 1117-1117
ANTITUMOR FUNCTIONS OF IP-10 AND MIG
Authors: TANNENBAUM CS TUBBS R ARMSTRONG D FINKE J BUKOWSKI R HAMILTON T
Citation: Cs. Tannenbaum et al., ANTITUMOR FUNCTIONS OF IP-10 AND MIG, Journal of leukocyte biology, 1997, pp. 70-70
IMPACT OF THERAPY WITH EPOETIN ALFA ON CLINICAL OUTCOMES IN PATIENTS WITH NONMYELOID MALIGNANCIES DURING CANCER-CHEMOTHERAPY IN COMMUNITY ONCOLOGY PRACTICE
Authors: GLASPY J BUKOWSKI R STEINBERG D TAYLOR C TCHEKMEDYIAN S VADHANRAJ S
Citation: J. Glaspy et al., IMPACT OF THERAPY WITH EPOETIN ALFA ON CLINICAL OUTCOMES IN PATIENTS WITH NONMYELOID MALIGNANCIES DURING CANCER-CHEMOTHERAPY IN COMMUNITY ONCOLOGY PRACTICE, Journal of clinical oncology, 15(3), 1997, pp. 1218-1234
TUMOR-INDUCED SUPPRESSION OF T-LYMPHOCYTE PROLIFERATION COINCIDES WITH INHIBITION OF JAK3 EXPRESSION AND IL-2 RECEPTOR SIGNALING - ROLE OF SOLUBLE PRODUCTS FROM HUMAN RENAL-CELL CARCINOMAS
Authors: KOLENKO V WANG Q RIEDY MC OSHEA J RITZ J CATHCART MK RAYMAN P TUBBS R EDINGER M NOVICK A BUKOWSKI R FINKE J
Citation: V. Kolenko et al., TUMOR-INDUCED SUPPRESSION OF T-LYMPHOCYTE PROLIFERATION COINCIDES WITH INHIBITION OF JAK3 EXPRESSION AND IL-2 RECEPTOR SIGNALING - ROLE OF SOLUBLE PRODUCTS FROM HUMAN RENAL-CELL CARCINOMAS, The Journal of immunology, 159(6), 1997, pp. 3057-3067
PAIR POTENTIAL FOR WATER FROM SYMMETRY-ADAPTED PERTURBATION-THEORY
Authors: MAS EM SZALEWICZ K BUKOWSKI R JEZIORSKI B
Citation: Em. Mas et al., PAIR POTENTIAL FOR WATER FROM SYMMETRY-ADAPTED PERTURBATION-THEORY, The Journal of chemical physics, 107(11), 1997, pp. 4207-4218
HELIUM DIMER POTENTIAL FROM SYMMETRY-ADAPTED PERTURBATION-THEORY CALCULATIONS USING LARGE GAUSSIAN GEMINAL AND ORBITAL BASIS-SETS
Authors: KORONA T WILLIAMS HL BUKOWSKI R JEZIORSKI B SZALEWICZ K
Citation: T. Korona et al., HELIUM DIMER POTENTIAL FROM SYMMETRY-ADAPTED PERTURBATION-THEORY CALCULATIONS USING LARGE GAUSSIAN GEMINAL AND ORBITAL BASIS-SETS, The Journal of chemical physics, 106(12), 1997, pp. 5109-5122
COMPLETENESS CRITERIA FOR EXPLICITLY CORRELATED GAUSSIAN GEMINAL BASES OF AXIAL SYMMETRY
Authors: JEZIORSKI B BUKOWSKI R SZALEWICZ K
Citation: B. Jeziorski et al., COMPLETENESS CRITERIA FOR EXPLICITLY CORRELATED GAUSSIAN GEMINAL BASES OF AXIAL SYMMETRY, International journal of quantum chemistry, 61(5), 1997, pp. 769-776
PROSTAGLANDIN E(2) (PGE(2)) MODULATES THE EXPRESSION OF JAK3 IN NAIVEAND ACTIVATED T-LYMPHOCYTES
Authors: KOLENKO V BUKOWSKI R FINKE J
Citation: V. Kolenko et al., PROSTAGLANDIN E(2) (PGE(2)) MODULATES THE EXPRESSION OF JAK3 IN NAIVEAND ACTIVATED T-LYMPHOCYTES, The FASEB journal, 10(6), 1996, pp. 2610-2610
SUPPRESSION OF NF-KAPPA-B ACTIVATION IN NORMAL T-CELLS BY SOLUBLE PRODUCTS FROM RENAL-CELL CARCINOMA EXPLANTS
Authors: FINKE J RAYMAN P LI X LIU J HAMILTON T KIM HJ TUBBS R NOVICK A BUKOWSKI R
Citation: J. Finke et al., SUPPRESSION OF NF-KAPPA-B ACTIVATION IN NORMAL T-CELLS BY SOLUBLE PRODUCTS FROM RENAL-CELL CARCINOMA EXPLANTS, The FASEB journal, 10(6), 1996, pp. 2717-2717
SUPPRESSION OF TCR-CD3 LINKED TYROSINE PHOSPHORYLATION OF NORMAL PERIPHERAL-BLOOD T-CELLS BY TUMOR SUPERNATANTS FROM RENAL-CELL CARCINOMA (RCC)
Authors: WANG Q KOLENKO V RAYMAN P TUBBS R NOVICK A BUKOWSKI R FINKE J
Citation: Q. Wang et al., SUPPRESSION OF TCR-CD3 LINKED TYROSINE PHOSPHORYLATION OF NORMAL PERIPHERAL-BLOOD T-CELLS BY TUMOR SUPERNATANTS FROM RENAL-CELL CARCINOMA (RCC), The FASEB journal, 10(6), 1996, pp. 2720-2720
EFFECTS OF INTERLEUKIN-12 ON INTERFERON-GAMMA PRODUCTION BY PERIPHERAL-BLOOD AND TUMOR-INFILTRATING T-LYMPHOCYTES FROM RENAL-CELL CARCINOMAPATIENTS - EVIDENCE OF IMPAIRED SECRETION
Authors: ULCHAKER J PANUTO J KOLENKO V RAYMAN P NOVICK A ELSON P TUBBS R BUKOWSKI R FINKE J
Citation: J. Ulchaker et al., EFFECTS OF INTERLEUKIN-12 ON INTERFERON-GAMMA PRODUCTION BY PERIPHERAL-BLOOD AND TUMOR-INFILTRATING T-LYMPHOCYTES FROM RENAL-CELL CARCINOMAPATIENTS - EVIDENCE OF IMPAIRED SECRETION, The FASEB journal, 10(6), 1996, pp. 2723-2723
PHASE-II STUDY OF ELSAMITRUCIN (BMY-28090) FOR THE TREATMENT OF PATIENTS WITH REFRACTORY RELAPSED NON-HODGKINS-LYMPHOMA/
Authors: ALLEN SL SCHACTER LP LICHTMAN SM BUKOWSKI R FUSCO D HENSLEY M ODWYER P MITTELMAN A ROSENBLOOM B HUYBENSZ S
Citation: Sl. Allen et al., PHASE-II STUDY OF ELSAMITRUCIN (BMY-28090) FOR THE TREATMENT OF PATIENTS WITH REFRACTORY RELAPSED NON-HODGKINS-LYMPHOMA/, Investigational new drugs, 14(2), 1996, pp. 213-217
FABRY-PEROT-INTERFEROMETER IN BRILLOUIN-SCATTERING EXPERIMENTS
Authors: BLACHOWICZ T BUKOWSKI R KLESZCZEWSKI Z
Citation: T. Blachowicz et al., FABRY-PEROT-INTERFEROMETER IN BRILLOUIN-SCATTERING EXPERIMENTS, Review of scientific instruments, 67(12), 1996, pp. 4057-4060
Risultati: 1-25 | 26-50 | 51-52